Wu S, Calero-Pérez P, Villamañan L, Arias-Ramos N, Pumarola M, Ortega-Martorell S, Julià-Sapé M, Arús C, Candiota AP. Anti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological images. NMR Biomed. 2020 Apr;33(4):e4229. doi: 10.1002/nbm.4229. Epub 2020 Jan 11. PMID: 31926117.
Núñez LM, Romero E, Julià-Sapé M, Ledesma-Carbayo MJ, Santos A, Arús C, Candiota AP, Vellido A. Unraveling response to temozolomide in preclinical GL261 glioblastoma with MRI/MRSI using radiomics and signal source extraction. Sci Rep. 2020 Nov 12;10(1):19699. doi: 10.1038/s41598-020-76686-y. PMID: 33184423; PMCID: PMC7661707.
Wu S, Calero-Pérez P, Arús C, Candiota AP. Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches. Int J Mol Sci. 2020 Nov 20;21(22):8775. doi: 10.3390/ijms21228775. PMID: 33233585; PMCID: PMC7699815.
Casaña-Eslava RV, Ortega-Martorell S, Lisboa PJ, Candiota AP, Julià-Sapé M, Martín-Guerrero JD, Jarman IH. Robust Conditional Independence maps of single-voxel Magnetic Resonance Spectra to elucidate associations between brain tumours and metabolites. PLoS One. 2020 Jul 1;15(7):e0235057. doi: 10.1371/journal.pone.0235057. PMID: 32609725; PMCID: PMC7329095.
Pi Castro D, José-López R, Fernández Flores F, Rabanal Prados RM, Mandara MT, Arús C, Pumarola Batlle M. Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes. J Neuropathol Exp Neurol. 2020 Feb 1;79(2):184-193. doi: 10.1093/jnen/nlz120. PMID: 31846038.
